Compare
Solesence, Inc. vs Karbon-X Corp. vs Axil Brands, Inc. vs cbdMD, Inc.
| Latest fiscal year | Solesence, Inc. SLSN | Karbon-X Corp. KARX | Axil Brands, Inc. AXIL | cbdMD, Inc. YCBD |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2026-05-31 | 2026-05-31 | 2025-09-30 |
| Revenue | $62.06M | $55.86M | $30.85M | $19.19M |
| Revenue growth (YoY) | +18.6% | n/m | +17.5% | -1.5% |
| Gross margin | 25.9% | 1.5% | 69.3% | 62.4% |
| Operating margin | 2.5% | -19.8% | 9.7% | -11.3% |
| Net margin | 2.9% | -24.3% | 8.8% | -10.6% |
| Net income | $1.79M | -$13.59M | $2.70M | -$2.04M |
| EPS (Diluted) | $0.02 | -$0.16 | $0.33 | -$1.09 |
| Operating cash flow | -$8.57M | -$7.86M | -$9.6K | -$1.45M |
| Free cash flow | n/a | -$7.87M | -$89.0K | -$1.64M |
| Cash & equivalents | $1.29M | n/a | $4.46M | $2.26M |
| Total assets | $50.05M | $9.62M | $17.96M | $10.42M |
| Total liabilities | n/a | $15.60M | $4.81M | $3.19M |
| Shareholders' equity | $17.63M | -$5.98M | $13.14M | $7.23M |
| Return on year-end equity | 10.2% | n/a | 20.5% | -28.2% |
| Shares outstanding | 70.61M | 94.89M | 6.82M | 8.92M |
Revenue, most recent five fiscal years
| Fiscal year | Solesence, Inc. | Karbon-X Corp. | Axil Brands, Inc. | cbdMD, Inc. |
|---|---|---|---|---|
| Latest | $62.06M Ended 2025-12-31 | $55.86M Ended 2026-05-31 | $30.85M Ended 2026-05-31 | $19.19M Ended 2025-09-30 |
| 1 year earlier | $52.35M Ended 2024-12-31 | $3.16M Ended 2025-05-31 | $26.26M Ended 2025-05-31 | $19.48M Ended 2024-09-30 |
| 2 years earlier | $37.30M Ended 2023-12-31 | $412.1K Ended 2024-05-31 | $27.50M Ended 2024-05-31 | $24.16M Ended 2023-09-30 |
| 3 years earlier | $37.32M Ended 2022-12-31 | $9.8K Ended 2023-05-31 | $23.52M Ended 2023-05-31 | $35.40M Ended 2022-09-30 |
| 4 years earlier | $29.48M Ended 2021-12-31 | $0 Ended 2022-05-31 | $2.34M Ended 2022-05-31 | $44.48M Ended 2021-09-30 |